172 filings
Page 3 of 9
8-K
51wjpf
13 Jun 22
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
v0c1x3pm9mah566utr
11 May 22
Trevena Reports First Quarter 2022 Results and Provides
7:05am
8-K
ubvydov1tze aepd
25 Apr 22
Other Events
7:01am
8-K
lwbmho54656vk
20 Apr 22
Regulation FD Disclosure
5:11pm
8-K
ib4 5fbtmob4th
20 Apr 22
Trevena Announces Results from Respiratory Physiology Study of Head-to-Head Comparison of OLINVYK® and IV Morphine in Elderly/Overweight Subjects
8:59am
8-K
fmayc6pmdwwfbz4dkf
31 Mar 22
Trevena Receives up to $40M in OLINVYK ex-US Royalty-Based Financing
7:05am
8-K
ah58x8 7gz
31 Mar 22
Trevena Reports Fourth Quarter and Full Year 2021 Results
7:04am
8-K
jhs mf9b2
27 Jan 22
Trevena Announces Submission of New Drug Application in China for OLINVYK® by its Partner Jiangsu Nhwa Pharmaceutical
9:04am
8-K
nhe db7lg
23 Dec 21
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:06pm
8-K
394m5 ax0
15 Nov 21
Trevena Reports Third Quarter 2021 Results
9:24pm
8-K
2lftax6erc5uv 2ymz7
4 Oct 21
Other Events
6:02am
8-K
5976v2q 8cu4vkjg5z
7 Sep 21
Other Events
4:05pm
8-K
3jsf yee0zmcf
12 Aug 21
Trevena Reports Second Quarter 2021 Results
8:02am
8-K
gvut6mics1m e5qvf
4 Aug 21
Other Events
4:04pm
8-K
l7iil5xt69 w0br4k8dk
16 Jun 21
Regulation FD Disclosure
4:08pm
8-K
oumbwy0
28 May 21
Other Events
5:23pm
8-K
78ncvq
14 May 21
Submission of Matters to a Vote of Security Holders
4:17pm
8-K
7jgdst
6 May 21
Trevena Reports First Quarter 2021 Results
7:05am
8-K
z7x2zimoyc r1ap6
21 Apr 21
Regulation FD Disclosure
7:05am
8-K
qnalib25yra7f4edo1j
18 Mar 21
Trevena, Inc. Appoints Marvin H. Johnson, Jr. to Board of Directors
7:01am